RobertNormanTaubMD

Oncology • New York, NY

Hematologic Oncology, Sarcoma

Physician

Join to view full profile

Dr. Taub is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Taub's full profile

Already have an account?

Office
47 E 88th St
Apt 11A
New York, NY 10128
Is this information wrong?

Education & Training

Tufts Medical CenterResidency, Internal Medicine, 1963 - 1966
Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1962 - 1963
Tufts Medical CenterInternship, Internal Medicine, 1961 - 1962
Yale School of MedicineClass of 1961
Yale-New Haven Medical CenterFellowship, Medical Oncology

Certifications & Licensure

NY State Medical License 1968 - 2026
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1974

Clinical Trials

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Start of enrollment: 1998 Sep 01
Unknown status
Phase 2
Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma Start of enrollment: 1997 Jul 01
Unknown status
Phase 2
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery Start of enrollment: 1999 Feb 01
Completed
Phase 2
CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2000 Oct 01
Unknown status
Phase 2
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer Start of enrollment: 2001 May 01
Unknown status
Phase 2
Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma Start of enrollment: 2001 Oct 01
Unknown status
Phase 2
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma Start of enrollment: 2002 Mar 01
Unknown status
Phase 2
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide Start of enrollment: 2007 Oct 01
Unknown status
Phase 1
Sunitinib in Certain Subtypes of Soft Tissue Sarcomas Start of enrollment: 2007 Apr 01
Terminated
Phase 2
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma Start of enrollment: 2004 Apr 01
Completed
Phase 2
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma Start of enrollment: 2008 Feb 01
Terminated
Phase 2
Alimta Plus Gemcitabine for Advanced Sarcoma Start of enrollment: 2005 Aug 01
Completed
Phase 2
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma Start of enrollment: 2009 Sep 01
Unknown status
Phase 2
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed Start of enrollment: 2010 Apr 12
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

8 citations
Two-Stage Cytoreductive Surgery and Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma: Predictors of Overall Survival in an Intention-to-Treat...
Joshua Leinwand, Robert N. Taub, John A. Chabot, Michael D. Kluger> ;Annals of Surgical Oncology. 2020 Jul 1
4 citations
50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience.
Allison S. Letica-Kriegel, Joshua Leinwand, Joshua R. Sonett, Lyall A. Gorenstein, Robert N. Taub, John A. Chabot, Michael D. Kluger> ;Annals of Surgical Oncology. 2020 Jan 1
41 citations
Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases.
Radhika Tandon, Yuis Jimenez-Cortez, Robert N. Taub, Alain C. Borczuk> ;Archives of Pathology & Laboratory Medicine. 2017 Oct 19
8 citations
Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal Chemotherapy
Danielle R. Heller, Cody Chiuzan, Robert N. Taub, Joshua Leinwand, Allison M. Greene, Gleneara E. Bates, John A. Chabot, Michael D. Kluger> ;Annals of Surgical Oncology. 2017 Oct 12
3 citations
Intimacy, Body Image, and Cancer.
Gleneara E. Bates, Robert N. Taub, Howard Jack West> ;JAMA Oncology. 2016 Dec 1
131 citations
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.
Christopher W. Ryan, Ofer Merimsky, Mark Agulnik, Jean-Yves Blay, Scott M. Schuetze, Brian A. Van Tine, Robin L. Jones, Anthony D. Elias, Edwin Choy, Thierry Alcindor,...> ;Journal of Clinical Oncology. 2016 Sep 12
Approach to offering remote support to mesothelioma patients: the mesothelioma survivor project.
Gleneara E. Bates, Anisah Khurshid Hashmi, Toby Bressler, Jill Zajac, Mary Hesdorffer, Robert N. Taub> ;Translational Lung Cancer Research. 2016 Jun 20
12 citations
Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma.
Anna Domènech-Vilardell, Michael J Rasiej, Robert N. Taub, Masanori Ichise> ;The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2016 Mar 1
36 citations
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration
Alain C. Borczuk, Jianming Pei, Robert N. Taub, Brynn Levy, Odelia Nahum, Jinli Chen, Katherine Chen, Joseph R. Testa> ;Cancer Biology & Therapy. 2016 Feb 6
10 citations
Fertility and Cancer Treatment.
Gleneara E. Bates, Robert N. Taub, Howard Jack West> ;JAMA Oncology. 2016 Feb 1
Approach to offering remote support to mesothelioma patients: The Mesothelioma Survivor Project.
Bressler, T.,Hashmi, A. K.,Hesdorffer, M.,Taub, R. N.> ;J. Clin. Oncol.. 2017 Feb 06
22 citations
Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma.
Alyssa M. Krasinskas, Alain C. Borczuk, Douglas J. Hartman, John A. Chabot, Robert N. Taub, Ashish Mogal, James F. Pingpank, David L. Bartlett, Sanja Dacic> ;Histopathology. 2016 Apr 1
9 citations
Quantitative X-ray Computed Tomography Peritoneography in Malignant Peritoneal Mesothelioma Patients Receiving Intraperitoneal Chemotherapy
Joshua Leinwand, Binsheng Zhao, Xiaotao Guo, Saravanan Krishnamoorthy, Jing Qi, Joseph Graziano, Vesna N. Slavkovic, Gleneara E. Bates, Sharyn N. Lewin, John D. Allend...> ;Annals of Surgical Oncology. 2013 May 24
9 citations
Body Surface Area Predicts Plasma Oxaliplatin and Pharmacokinetic Advantage in Hyperthermic Intraoperative Intraperitoneal Chemotherapy
Joshua Leinwand, Gleneara E. Bates, John D. Allendorf, John A. Chabot, Sharyn N. Lewin, Robert N. Taub> ;Annals of Surgical Oncology. 2013 Mar 2
60 citations
A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma
Jonathan E. Dowell, Frank Dunphy, Robert N. Taub, David E. Gerber, Likheng Ngov, Jingsheng Yan, Yang Xie, Hedy L. Kindler> ;Lung Cancer. 2012 Sep 1
10 citations
Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma
Igor Matushansky, Robert N. Taub> ;Nature Reviews. Clinical Oncology. 2011 Mar 22
22 citations
Utility of Glucose Transporter 1 in the Distinction of Benign and Malignant Thoracic and Abdominal Mesothelial Lesions
Stephen M. Lagana, Robert N. Taub, Alain C. Borczuk> ;Archives of Pathology & Laboratory Medicine. 2012 Jun 28
52 citations
PPARγ agonists enhance ET-743–induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma
Elizabeth Charytonowicz, Melissa Terry, Katherine Coakley, Leonid Telis, Fabrizio Remotti, Carlos Cordon-Cardo, Robert N. Taub, Igor Matushansky> ;The Journal of Clinical Investigation. 2012 Mar 1
A phase I dose-escalation study of azacitidine in combination with temozolomide in patients with soft tissue sarcomas.
Matushansky I, Coakley KE, Uldrick TS, Taub RN> ;J. Clin. Oncol.. 2011-05-20
Repeated ambulatory intrapleural chemotherapy for malignant pleural mesothelioma.
Javidfar J, Sonett JR, Ginsburg ME, Miller J, Hare E, Bacchetta M, Fawwaz R, Taub RN> ;J. Clin. Oncol.. 2011-05-20
16 citations
Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II t...
Michael D. Kluger, Robert N. Taub, Mary Hesdorffer, Zhezhen Jin, John A. Chabot> ;European Journal of Surgical Oncology. 2010 Oct 1
A multicenter phase II study of pemetrexed (P), cisplatin (C), and bevacizumab (B) in patients (pts) with advanced malignant mesothelioma (MM).
Dowell J, Taub R, Lan C, Xie Y, Dunphy F, Blake V, Kindler H> ;J. Clin. Oncol.. 2009-05-20
Use of laser capture microdissection to derive poor prognosis gene expression signatures of epithelial abdominal malignant mesothelioma.
Borczuk AC, Chen J, Parikh F, Powell CA, Taub RN> ;J. Clin. Oncol.. 2009-05-20
Influence of microscopic malignant peritoneal mesothelioma on posttreatment survival.
Kluger MD, Chabot JA, Hesdorffer M, DeRosa CM, Taub RN> ;J. Clin. Oncol.. 2009-05-20
14 citations
Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma.
Michelle S. Boyar, Mary Hesdorffer, Mary Louise Keohan, Zhezhen Jin, Robert N. Taub> ;Sarcoma. 2008 Nov 16
Join now to see all

Grant Support

Moab-Dnr Conjugates For Therapy--Drug Resistant LeukemiaNational Cancer Institute1989
Moab:Dnr Conjugates For Therapy Of Drug Resistant LeukemNational Cancer Institute1988
Membrane Sialoglycoconjugates And SialyltransferasesNational Cancer Institute1988
Membrane Sialoglycoconjugates And Sialyltransferases InNational Cancer Institute1986–1987
DNR Conjugates For Therapy Of Drug Resistant LeukemiaNational Cancer Institute1986